Literature DB >> 18395238

A subset of equine sarcoids harbours BPV-1 DNA in a complex with L1 major capsid protein.

S Brandt1, R Haralambus, S Shafti-Keramat, R Steinborn, C Stanek, R Kirnbauer.   

Abstract

Bovine papillomavirus type 1 or 2 (BPV-1, BPV-2) are accepted causal factors in equine sarcoid pathogenesis. Whereas viral genomes are consistently found and expressed within lesions, intact virions have never been detected, thus permissiveness of sarcoids for BPV-1 replication remains unclear. To reassess this issue, an immunocapture PCR (IC/PCR) was established using L1-specific antibodies to capture L1-DNA complexes followed by amplification of the viral genome. Following validation of the assay, 13 sarcoid-bearing horses were evaluated by IC/PCR. Samples were derived from 21 tumours, 4 perilesional/intact skin biopsies, and 1 serum. Tissue extracts from sarcoid-free equines served as controls. IC/PCR scored positive in 14/24 (58.3%) specimens obtained from sarcoid-patients, but negative for controls. Quantitative IC/PCR demonstrated <125 immunoprecipitable viral genomes/50 microl extract for the majority of specimens. Moreover, full-length BPV-1 genomes were detected in a complex with L1 proteins. These complexes may correspond to virion precursors or intact virions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18395238     DOI: 10.1016/j.virol.2008.02.014

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  9 in total

1.  Analysis of the long control region of bovine papillomavirus type 1 associated with sarcoids in equine hosts indicates multiple cross-species transmission events and phylogeographical structure.

Authors:  Hannah Trewby; Gizachew Ayele; Giuseppe Borzacchiello; Sabine Brandt; M Saveria Campo; Claudia Del Fava; Johan Marais; Leonardo Leonardi; Barbara Vanselow; Roman Biek; Lubna Nasir
Journal:  J Gen Virol       Date:  2014-09-03       Impact factor: 3.891

2.  Safety and immunogenicity of BPV-1 L1 virus-like particles in a dose-escalation vaccination trial in horses.

Authors:  E K Hainisch; S Brandt; S Shafti-Keramat; R Van den Hoven; R Kirnbauer
Journal:  Equine Vet J       Date:  2011-09-06       Impact factor: 2.888

3.  Screening for bovine papillomavirus type 13 (BPV13) in a European population of sarcoid-bearing equids.

Authors:  Christoph Jindra; Ann-Kristin Kamjunke; Sarah Jones; Sabine Brandt
Journal:  Equine Vet J       Date:  2021-08-30       Impact factor: 2.692

4.  Inoculation of young horses with bovine papillomavirus type 1 virions leads to early infection of PBMCs prior to pseudo-sarcoid formation.

Authors:  Bettina Hartl; Edmund K Hainisch; Saeed Shafti-Keramat; Reinhard Kirnbauer; Annunziata Corteggio; Giuseppe Borzacchiello; Reinhard Tober; Christina Kainzbauer; Barbara Pratscher; Sabine Brandt
Journal:  J Gen Virol       Date:  2011-06-29       Impact factor: 3.891

5.  Both tumour cells and infiltrating T-cells in equine sarcoids express FOXP3 associated with an immune-supressed cytokine microenvironment.

Authors:  A Douglas Wilson; Chelsea Hicks
Journal:  Vet Res       Date:  2016-05-09       Impact factor: 3.683

6.  Epitheliotropic Infections in Wildlife Ruminants From the Central Alps and Stelvio National Park.

Authors:  Laura Gallina; Federica Savini; Giovanni Casà; Irene Bertoletti; Alessandro Bianchi; Lucia Rita Gibelli; Davide Lelli; Antonio Lavazza; Alessandra Scagliarini
Journal:  Front Vet Sci       Date:  2020-04-30

7.  Molecular Detection of Bovine Papillomavirus DNA in the Placenta and Blood of Healthy Mares and Respective Foals.

Authors:  Federica Savini; Laura Gallina; Francesca Mazza; Jole Mariella; Carolina Castagnetti; Alessandra Scagliarini
Journal:  Vet Sci       Date:  2019-02-06

8.  Influenza virus vector iNS1 expressing bovine papillomavirus 1 (BPV1) antigens efficiently induces tumour regression in equine sarcoid patients.

Authors:  Christoph Jindra; Edmund K Hainisch; Andrea Rümmele; Markus Wolschek; Thomas Muster; Sabine Brandt
Journal:  PLoS One       Date:  2021-11-19       Impact factor: 3.240

9.  New approach for genomic characterisation of equine sarcoid-derived BPV-1/-2 using nanopore-based sequencing.

Authors:  Lien Gysens; Bert Vanmechelen; Maarten Haspeslagh; Ann Martens; Piet Maes
Journal:  Virol J       Date:  2022-01-06       Impact factor: 4.099

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.